Kazuyuki Matsushita | Neurodevelopmental Processes | Research Excellence Award

Published on by Neuroscientists

Prof. Dr. Kazuyuki Matsushita | Neurodevelopmental Processes | Research Excellence Award

Prof. Dr. Kazuyuki Matsushita | Chiba University Hospital | Japan

Kazuyuki Matsushita is a senior academic and clinical scientist at Chiba University, Japan, with extensive expertise in laboratory medicine and translational diagnostics. He is affiliated with the Department of Laboratory Medicine, which integrates advanced sections including clinical chemistry, hematology, clinical microbiology, medical physiology, blood collection services, and genetic testing, all operating under internationally recognized analytical standards to ensure accurate, reproducible, and rapid assessment of physiological and pathological conditions. His work emphasizes the critical role of laboratory medicine in improving diagnostic precision and patient care. The clinical microbiology laboratory under his academic environment has made substantial contributions to infection control and hospital-based disease management, while genetic testing activities are closely aligned with clinical genetics to support precision medicine. A central focus of his research is the identification and validation of novel biomarkers and clinically meaningful indicators that enhance diagnosis, prognosis, and therapeutic decision-making beyond routine laboratory practice. His scholarly impact is reflected in 196 peer-reviewed documents, an h-index of 33, and 3,702 citations across 3,205 citing documents, demonstrating sustained influence in laboratory medicine, clinical microbiology, and diagnostic innovation at both national and international levels.

Citation Metrics (Scopus)

4000
3000
2000
1000
0

Citations
3702

Documents
196

h-index
33

Citations

Documents

h-index

View Scopus Profile View OrcidProfile

Featured Publications

Genetic Variation in Background Mucosa Across Different Grades of Chronic Esophagitis
– Journal of Gastroenterology and Hepatology Australia, 2025

Adil el Housseini | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Adil el Housseini | Cellular Neuroscience | Best Researcher Award

Mr. Adil el Housseini | Ibn Zohr University Agadir Morocco | Morocco

Adil EL Housseini is a dedicated PhD candidate in biology at Ibn Zohr University, Faculty of Sciences of Agadir, specializing in toxicology, biochemistry, and the molecular characterization of scorpion venoms. His doctoral research explores the biochemical composition, ecotoxicity, and pathophysiological mechanisms of venoms from selected Buthid species, with a particular focus on developing novel therapeutic strategies for scorpion envenomation. Adil has contributed to the scientific community through peer-reviewed publications and authored book chapters spanning biomedical polymers, chitosan-based therapeutic applications, radioprotective biomaterials, and neurobiological insights into astrocyte function. His work on the kinetics of brain oxidative stress following scorpion envenomation highlights his strong command of experimental toxicology and neurobiochemical analysis. With an h-index of 1, two indexed documents, and two citations, he continues to build a research profile grounded in rigorous experimentation and interdisciplinary scientific inquiry. Adil’s skills include venom biochemistry, laboratory toxicology, data interpretation, and scientific writing, supported by strong language proficiency in Arabic, French, and English. His commitment to advancing knowledge in venom toxicology and biomedical sciences positions him as a promising emerging researcher contributing to both fundamental understanding and applied therapeutic innovation.

Profile: Google Scholar | Orcid

Featured Publications

Ait Hamdan, Y., Rhazi, M., El-Mansoury, B., Kabdy, H., Oukhrib, M., Ait Baba, A., … (2024). Astrocytes functions and their involvement in brain injury: A focus on the biomaterials’ role in mitigating traumatic brain injury. In Physiology and Function of Glial Cells in Health and Disease (pp. 145–163).

Mabsor-Zgandaoui, S., Rachmoune, K., Aftais, I., Elamrani, F. E., Amradi, I., … (2026). Biomedical polymers: Foundations and future innovations in medicine. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Ait Hamdan, Y., Armadi, I., Elamrani, F. E., Mekouar, M., El Housseini, A., … (2026). Therapeutic implications of chitosan and its derivatives: Focus on cancer treatment. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Rachmoune, K., Mabsor-Zgandaoui, S., El Housseini, A., Ait Hamdan, Y., … (2026). Radioprotective effects of chitosan polysaccharides and biomedical applications. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Armadi, I., Elouali, S., Abana, A., El Housseini, A., Loqman, S., & Belbachir, A. (2025). Overview of biomaterials classification, properties, and biomedical applications. In Innovations and Applications of Advanced Biomaterials in Healthcare 

Hui Gan | Molecular and Cellular Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Hui Gan | Molecular and Cellular Neuroscience | Research Excellence Award

Dr. Hui Gan | Chongqing Medical University | China

Professor Hui Gan is a distinguished researcher at Chongqing Medical University, serving as a master’s supervisor, associate research fellow, and Assistant to the Dean of the School of Basic Medical Sciences, where she also leads the Department of Pathophysiology in an acting capacity. Her research primarily focuses on neuroinflammation, microglial regulation, and inflammasome-mediated injury following cerebral hemorrhage, with significant contributions to understanding TRIM21-mediated mechanisms and microglial transcriptional pathways such as c-MAF–NLRP3 signaling. She has secured multiple competitive national and regional research grants supporting investigations into inflammasome activation, microcirculatory dysfunction, and post-hemorrhagic inflammatory injury. Professor Gan has received notable recognitions, including awards for early-career excellence and contributions to microcirculation research. She plays an active role in professional societies as a committee member of the Microcirculation Committee of the Chinese Society of Pathophysiology and a young committee member of the Translational Medicine Committee of the Chinese Society of Microcirculation, contributing to academic development in basic and translational medical sciences. Her scholarly output includes 18 documents, with 196 citations across 175 citing documents, reflecting a solid research impact supported by an h-index of 8. Through her scientific leadership and innovative research, she continues to advance understanding of inflammatory mechanisms in neurological injury.

Profile: Scopus

Featured Publication

Gan, H., Gan, H.-Y., Zhang, M., Duan, Y., Palahati, A., He, Q., Tan, J., Li, Y., Zhai, X., & Zhao, J. (2025). Microglial NFAT5 aggravates neuroinflammation via mediating NLRP6 inflammasome in experimental ischemic stroke. Genes and Diseases, 12(6),

Zhi Li | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Zhi Li | Molecular and Cellular Neuroscience | Best Researcher Award

Assist. Prof. Dr. Zhi Li | Qinghai University | China

Zhi Li is a researcher specializing in cellular biology, infection and immunity, host–pathogen interactions, vector and vector-borne diseases, and zoonoses. His work focuses on understanding the molecular mechanisms underlying host responses to parasitic infections and the epidemiology of emerging infectious diseases in animals. As an Assistant Professor at Qinghai University, he has contributed significantly to research on parasitic pathogens affecting livestock and wildlife in the Qinghai-Tibetan Plateau region. His studies have explored infections caused by Echinococcus shiquicus, Theileria annulata, and various fluke species, emphasizing their identification, transmission dynamics, and host interactions. Through collaborations with national and international researchers, he has published in leading journals such as Transboundary and Emerging Diseases, Parasitology Research, Parasites & Vectors, and Acta Tropica. His research integrates molecular biology, immunological assays, and field epidemiology to develop improved diagnostic tools and better understand pathogen adaptation in diverse ecological settings. By linking laboratory findings with field observations, Zhi Li’s work contributes to controlling zoonotic and vector-borne diseases that threaten both animal and human health, aligning with the global “One Health” approach that connects veterinary and biomedical research for sustainable disease management.

Profile: Orcid

Li, Z., Han, Y., Liu, J.-L., Zhang, X.-Y., Shen, X., Guo, Z.-H., Yin, H., Duo, H., & Fu, Y. (2025). High diversity of Piroplasm species carried by ticks from Qinghai, China. Acta Tropica, 250, 107907.

Fu, Y., Zhang, X., Li, Z., Shi, Z., Ma, X., Meng, R., Zhang, Q., Zhao, C., Guo, S., Ma, W., et al. (2023, November 23). Emerging Echinococcus shiquicus infection of Asian badgers in the Qinghai–Tibetan Plateau. Transboundary and Emerging Diseases, 2023, 6874033.

Fu, Y., Zhang, X., Li, Z., Meng, R., Duo, H., Shen, X., Ma, Y., & Guo, Z. (2023, July). Identification and prevalence of fluke infection in yak and Tibetan sheep around Qinghai Lake, China. Parasitology Research.

Zhang, X., Jian, Y., Li, Z., Duo, H., Guo, Z., & Fu, Y. (2023, February 25). Optimization of single-tube nested PCR for the detection of Echinococcus spp. Experimental Parasitology, 246, 108358.

Liu, J., Zhao, S., Li, Z., Zhang, Z., Zhao, B., Guan, G., Yin, H., & Luo, J. (2023, February 23). Activation of telomerase activity and telomere elongation of host cells by Theileria annulata infection. Frontiers in Microbiology, 14, 1123456.

Danai Veltra | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Danai Veltra | Neurogenetics and Molecular Neuroscience | Best Researcher Award 

Dr. Danai Veltra | National and Kapodistrian University | Greece

Dr. Danai Veltra is a Greek medical researcher specializing in clinical genetics and genomic medicine, with a strong focus on rare genetic disorders, epileptic encephalopathies, and neurodevelopmental syndromes. Her research contributions encompass genetic diagnostics through Next Generation Sequencing (NGS) and Whole Exome Sequencing (WES), significantly improving the identification and understanding of Mendelian and chromosomal disorders. She has presented her work at numerous prestigious international conferences, including the European Human Genetics Conference and the European Paediatric Neurology Society Congress, where she has contributed to studies on Marfan syndrome, Williams syndrome, Melnick-Needles syndrome, and Diamond Blackfan Anemia. Dr. Veltra has co-authored impactful publications in leading journals such as the European Journal of Paediatric Neurology, Gynecological Endocrinology, and American Journal of Medical Genetics. Her collaborative work has enhanced genotype–phenotype correlations and advanced precision medicine approaches in pediatric and hereditary diseases. With 237 citations, an h-index of 7, and an i10-index of 5, she has established herself as a promising scientist in medical genetics, contributing both to clinical application and academic advancement in human genomics and molecular diagnostics.

Profile: Google Scholar

Featured Publications

Marinakis, N. M., Svingou, M., Veltra, D., Kekou, K., Sofocleous, C., Tilemis, F. N., … (2021). Phenotype‐driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders. American Journal of Medical Genetics Part A, 185(8), 2561–2571.

Zouvelou, V., Yubero, D., Apostolakopoulou, L., Kokkinou, E., Bilanakis, M., … Veltra, D. (2019). The genetic etiology in cerebral palsy mimics: The results from a Greek tertiary care center. European Journal of Paediatric Neurology, 23(3), 427–437.

Tilemis, F. N., Marinakis, N. M., Veltra, D., Svingou, M., Kekou, K., Mitrakos, A., … (2023). Germline CNV detection through whole-exome sequencing (WES) data analysis enhances resolution of rare genetic diseases. Genes, 14(7), 1490.

Pavinato, L., Delle Vedove, A., Carli, D., Ferrero, M., Carestiato, S., Howe, J. L., … (2023). CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD. Brain, 146(2), 534–548.

Saffari, A., Lau, T., Tajsharghi, H., Karimiani, E. G., Kariminejad, A., Efthymiou, S., … (2023). The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders. Brain, 146(8), 3273–3288.

Layo-Carris, D. E., Lubin, E. E., Sangree, A. K., Clark, K. J., Durham, E. L., … (2024). Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals. European Journal of Human Genetics, 32(8), 928–937.

Veltra, D., Kosma, K., Papavasiliou, A., Tilemis, F. N., Traeger‐Synodinos, J., … (2022). A novel pathogenic ATP6V1B2 variant: Widening the genotypic spectrum of the epileptic neurodevelopmental phenotype. American Journal of Medical Genetics Part A, 188(12), 3563–3566.

Maansi Solanky | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Maansi Solanky | Molecular and Cellular Neuroscience | Best Researcher Award

Ms. Maansi Solanky | LSU Health New Orleans | United States

Maansi Solanky is a dedicated medical scholar pursuing her Doctor of Medicine at LSU Health New Orleans, with a strong interdisciplinary background in health and human sciences from the University of Southern California. Her academic journey integrates medicine, analytics, and public health, reflected in her extensive research and operational experience across multiple institutions. As an Operations Analyst at Evergreen Nephrology, she contributed to improving healthcare delivery through data-driven solutions, process optimization, and interdepartmental collaboration. Her research at the USC Keck School of Medicine explored neural communication mechanisms underlying schizophrenia and analyzed food insecurity in Los Angeles County using advanced data analytics. Additionally, her work with the Louisiana Organ Procurement Agency led to actionable insights enhancing organ donation efficiency through comparative data modeling in R, SQL, and SAS. With teaching experience as a Chemistry Supplemental Instruction Leader for over 700 students, she demonstrates a passion for mentorship and education. Maansi is also deeply engaged in community initiatives promoting public health and equitable healthcare access. She has authored 5 research documents, accumulated 42 citations, and holds an H-index of 3, underscoring her growing influence in medical research and data-driven healthcare innovation.

Profile: Oricd

Featured Publication

Solanky, M., Khosla, M., & Alahari, S. K. (2025). Assessing the tumor suppressive impact and regulatory mechanisms of SPDEF expression in breast cancer. Cancers, 17(21), 3556.

Kaviya Chinnappa | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Kaviya Chinnappa | Developmental Neuroscience | Best Researcher Award

Dr. Kaviya Chinnappa | Institute of Fer a Moulin (NeuroSU), Paris | France

Dr. Kaviya Chinnappa is a neuroscientist whose research focuses on the molecular and cellular mechanisms underlying cerebral cortex development, cortical progenitor dynamics, and neurodevelopmental disorders. She completed her Ph.D. in Neuroscience at the Instituto de Neurociencias (CSIC-UMH) in Alicante, Spain, and currently serves as a Postdoctoral Researcher at the Institut du Fer à Moulin (Inserm), Paris, where she investigates the role of ceramide synthase in neocortex formation and its association with cortical malformations such as heterotopia. Her work integrates advanced genetic, molecular, and imaging approaches to uncover regulatory pathways controlling neuronal proliferation, polarity, and differentiation. Dr. Chinnappa has contributed to several high-impact publications in journals including Nature, Science Advances, Journal of Cell Biology, Cells, Frontiers in Cell and Developmental Biology, BioEssays, Cerebellum, and Journal of Neurochemistry. Her studies have provided key insights into the roles of miRNAs, centrosomal proteins, and sphingolipid metabolism in brain development. She has received multiple distinctions, including the Extraordinary PhD Thesis Award and the Valérie Chamaillard Fellowship. With an h-index of 5, 4 i10-index publications, and 164 citations across 156 documents, Dr. Chinnappa continues to advance translational neuroscience through her innovative research on cortical development and neurogenetic disorders.

Profile: Google Scholar

Featured Publications

Camargo Ortega, G., Falk, S., Johansson, P. A., Peyre, E., Broix, L., Sahu, S. K., … (2019). The centrosome protein AKNA regulates neurogenesis via microtubule organization. Nature, 567(7746), 113–117.

Zaidi, D., Chinnappa, K., & Francis, F. (2022). Primary cilia influence progenitor function during cortical development. Cells, 11(18), 2895.

Chinnappa, K., Cárdenas, A., Prieto-Colomina, A., Villalba, A., … (2022). Secondary loss of miR-3607 reduced cortical progenitor amplification during rodent evolution. Science Advances, 8(2), eabj4010.

Prieto-Colomina, A., Fernández, V., Chinnappa, K., & Borrell, V. (2021). MiRNAs in early brain development and pediatric cancer: At the intersection between healthy and diseased embryonic development. BioEssays, 43(7), 2100073.

Chatterjee, A., Chinnappa, K., Ramanan, N., & Mani, S. (2018). Centrosome inheritance does not regulate cell fate in granule neuron progenitors of the developing cerebellum. The Cerebellum, 17(5), 685–691.

Zaidi, D., Chinnappa, K., Yigit, B. N., Viola, V., Cifuentes-Diaz, C., Jabali, A., … (2024). Forebrain Eml1 depletion reveals early centrosomal dysfunction causing subcortical heterotopia. Journal of Cell Biology, 223(12), e202310157.

Chinnappa, K., Márquez-Galera, Á., Prieto-Colomina, A., Nomura, Y., … (2019). MIR3607 regulates cerebral cortex development via activation of Wnt/βCat signaling. bioRxiv, 729939.

Chinnappa, K., Ballorin, F., & Francis, F. (2025). Fundamental Neurochemistry Review: Sphingolipids and ceramides in brain development. Journal of Neurochemistry, 169(10), e70262.

Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Published on by Neuroscientists

Dr. Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Dr. Efstratios Stylianos Pyrgelis | National and Kapodistrian University of Athens | Greece

Dr. Efstratios-Stylianos Pyrgelis is a distinguished Neurologist and Ph.D. scholar affiliated with the National and Kapodistrian University of Athens. His extensive research contributions span neurochemistry, neuroimaging, and normal pressure hydrocephalus, reflecting a deep commitment to advancing clinical neuroscience. With over 40 published articles in SCI- and Scopus-indexed journals and authorship of 4 international medical books, Dr. Pyrgelis has established a strong academic footprint. His scholarly influence is demonstrated by a total of 510 citations, an h-index of 11, and an i10-index of 12, as recorded on Google Scholar. As a Review Editor for Frontiers in Neurology and Guest Editor for Diagnostics, he plays a pivotal role in shaping contemporary neurological research. He collaborates with the CNS Alliance Research Group and maintains professional memberships with the Greek Neurologic Society and the Medical Association of Chios. Beyond academia, he has contributed to consultancy projects linking research with clinical applications. Through his innovative work and international collaborations, Dr. Pyrgelis continues to contribute significantly to the understanding and treatment of neurological disorders, reinforcing his reputation as one of Greece’s leading researchers in the field of neuroscience.

Profiles: Orcid | Research Gate

Featured Publications

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Stefanis, L., & Kapaki, E. (2024). In vivo prevalence of beta-amyloid pathology and Alzheimer’s disease co-pathology in idiopathic normal-pressure hydrocephalus—Association with neuropsychological features. Biomedicines, 12(8), 1898.

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Papaioannou, M., Stefanis, L., & Kapaki, E. (2023). Alzheimer’s disease CSF biomarkers as possible indicators of tap-test response in idiopathic normal pressure hydrocephalus. Brain Sciences, 13(11), 1593.

Angelopoulou, E., Pyrgelis, E.-S., Ahire, C., Suman, P., Mishra, A., & Piperi, C. (2023). Functional implications of protein arginine methyltransferases (PRMTs) in neurodegenerative diseases. Biology, 12(9), 1257.

Pyrgelis, E.-S., Velonakis, G., Papageorgiou, S. G., Stefanis, L., Kapaki, E., & Constantinides, V. C. (2023). Imaging markers for normal pressure hydrocephalus: An overview. Biomedicines, 11(5), 1265.

Constantinides, V. C., Paraskevas, G. P., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Stefanis, L., & Kapaki, E. (2023). CSF Aβ42 and Aβ42/Aβ40 ratio in Alzheimer’s disease and frontotemporal dementias. Diagnostics, 13(4), 783.

Constantinides, V. C., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Ghika, A., Koros, C., Liakakis, G., Papageorgiou, S., Stefanis, L., Paraskevas, G. P., et al. (2023). Application of the AT(N) and other CSF classification systems in behavioral variant frontotemporal dementia. Diagnostics, 13(3), 332.

Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2022). Emerging potential of the phosphodiesterase (PDE) inhibitor ibudilast for neurodegenerative diseases: An update on preclinical and clinical evidence. Molecules, 27(23), 8448.

Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Wagdy Khalil |  National Research Centre | Egypt

Dr. Wagdy Khalil is a Professor of Animal Genetics specializing in Molecular Genetics at the Cell Biology Department, National Research Centre, Egypt. His research focuses on genetic and molecular mechanisms underlying animal reproduction, gene expression, and environmental genotoxicity. He has significantly contributed to the understanding of oocyte maturation, preovulatory hormonal regulation, and molecular responses to toxins, nanoparticles, and natural therapeutic agents. Dr. Khalil’s work integrates molecular biology, biotechnology, and animal genetics to explore the genetic basis of fertility, mutagenicity, and disease resistance. He has published 161 scientific papers in peer-reviewed journals indexed in Scopus, reflecting his consistent research productivity and international collaboration. His studies have advanced knowledge in fields such as reproductive biology, toxicogenomics, molecular diagnostics, and genetic engineering. Dr. Khalil’s impactful research has earned him 2,055 citations from 1,801 documents, demonstrating wide recognition within the scientific community. With an h-index of 27, his work continues to influence emerging research in molecular genetics and biotechnology, bridging fundamental discoveries with applied biomedical and agricultural innovations.

Profiles: Scopus | Orcid | Google Scholar | Research Gate | Linked In

Featured Publications

  • Antiarthritic activities of berberine in a rat model of gouty arthritis. (2025). Scientific Reports.

  • Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. (2025). Scientific Reports.

  • Comparative study of pyridine and pyrimidine derivatives as promising anti-inflammatory agents: Design, synthesis, and LPS-induced RAW 264.7 macrophages. (2025). Drug Development Research.

  • Expression of growth factors in buffalo ovarian tissue across different follicular developmental stages. (2025). Archives of Gynecology and Obstetrics.

  • Estrus, preovulatory LH surge and oocyte maturation in Goettingen miniature pigs (Sus scrofa domesticus). (2025). Theriogenology.

  • Targeting apoptotic pathways in cancer: Design, synthesis, and molecular docking studies of 1,3,5-trisubstituted-1H-pyrazole derivatives with Bcl-2 inhibition and DNA damage potential. (2025). RSC Advances.

  • Assessment of the gold nanoparticles biosynthesized using Casuarina equisetifolia bark extract against the ethion-induced hepato- and neurotoxicity in rats. (2025). Journal of Genetic Engineering and Biotechnology.

  • In vitro and in vivo antidiabetic evaluation of new coumarin and chromone derivatives: Design, synthesis, and molecular modeling. (2025). Bioorganic Chemistry.

  • Potential therapeutic effects of interleukin-1 receptor type 1 antagonist and the ethyl acetate fraction of Murraya exotica leaves against κ-carrageenan-induced vein thrombosis in rats. (2025). Phytomedicine Plus.

  • The ability of stressor factors of environmental pollution to induce ROS and 8-OHdG mediated apoptosis in fish species of Suez Gulf, Red Sea. (2025). Egyptian Journal of Chemistry.

Noreen Kamal | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Dalhousie University | Canada

Dr. Noreen Kamal, Ph.D., P.Eng., is an Associate Professor of Industrial Engineering at Dalhousie University, Canada, with cross-appointments in the Departments of Community Health and Epidemiology and Medicine (Neurology). Her research lies at the intersection of health systems engineering and clinical neuroscience, focusing on the optimization of stroke care systems, development of data-driven quality improvement frameworks, and evaluation of biomedical devices for stroke rehabilitation. Dr. Kamal has played a pivotal role in advancing integrated approaches to enhance the efficiency, safety, and accessibility of acute stroke services across Canada. Prior to joining Dalhousie University, she held academic and leadership positions at the University of Calgary and the University of British Columbia, contributing extensively to clinical research and health technology innovation. Her work bridges engineering, medicine, and health policy, emphasizing interdisciplinary collaboration and patient-centered outcomes. With 107 scientific publications, 8,033 citations, and an h-index of 22, Dr. Kamal has established herself as a recognized scholar in healthcare systems improvement and translational neuroscience. Her scholarly and professional contributions continue to drive evidence-based innovation in stroke systems of care, supporting better clinical outcomes and sustainable health service delivery.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Author(s). (2025). Exploring differences in stroke treatment between urban and rural hospitals: A thematic analysis of practices in Canada. Canadian Journal of Neurological Sciences.

Author(s). (2025). Designing a patient outcome clinical assessment tool for modified Rankin Scale: “You feel the same way too”. Informatics.

Author(s). (2025). Predicting ischemic stroke patients to transfer for endovascular thrombectomy using machine learning: A case study. Healthcare (Switzerland).

Author(s). (2025). Incident prescriptions for common cardiovascular medications: Comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovascular Disorders.

Author(s). (2025). Rising out-of-hospital mortality in Canada during 2020–2022: A striking impact observed among young adults. Canadian Journal of Public Health.

Author(s). (2025). Discrete event simulation model of an acute stroke treatment process at a comprehensive stroke center: Determining the ideal improvement strategies for reducing treatment times. Journal of the Neurological Sciences.

Author(s). (2025). Validation of the Passive Surveillance Stroke Severity Score in three Canadian provinces. Canadian Journal of Neurological Sciences.

Author(s). (2025). A stochastic optimization model for designing disaster relief networks with congestion, disruption and distributional ambiguity. Infor.

Author(s). (2025). Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: A stepped-wedge trial. Frontiers in Neurology.

Author(s). (2025). The acute stroke system of treatment across Canada: Findings from a national stroke centre survey. Canadian Journal of Neurological Sciences.